This contributed to the development of the pharmaceutical ... molecule respectively Develop a polyclonal antibody against the entire ADC Nanobody/SCFV Develop single or one pair anti-idiotypic ...

Development strategy of anti-idiotypic antibodies ... screen anti-idiotypic antibodies against genetically engineered scFv antibodies used for PK analysis of CAR-T. For the PK or ADA assays ...

The development of bispecific antibody drugs ... classic bispecific antibodies, nanobodies, ScFv, and complex antibodies. This application meets the demanding needs of bispecific antibody design ...

Affitech uses a number of technologies for antibody discovery and development with collaborators ... has in-licensed diabody IP from Pharmexa and scFv IP from Micromet. The recently signed Roche ...

The antibody was created in a single-chain variable fragment (scFv) format, a small-sized artificial construct that retains the antigen-binding properties of the corresponding immunoglobulin G ...

Under the collaboration agreement, the parties will combine Harbour BioMed's industry-leading technology platform, proprietary dataset and extensive expertise in antibody development with Insilico ...

The Company owns an integrated end-to-end suite of capabilities to support the discovery and development of therapeutic antibodies and is known for solving complex industry challenges. IPA has ...

in vitro by anti-epidermal growth factor receptor antibody cetuximab Construction and targeting of a 5F11-scFv-methioninase fusion protein for antibody-directed enzyme pro-drug therapy (ADEPT) against ...

The crystal structure of the complex showed that, like scFv-2, fragment 4 recognized an epitope on the other side of the immunoglobulin domain from the complementarity-determining regions (CDRs) that ...